Flucytosine 500mg Capsule(export Only)

We are engaged in manufacturing, exporting, and supplying excellent quality Flucytosine 500mg Capsule in Jaipur, Rajasthan, India under brand of CYTOFLU as a substitute to ANCOBON / ANCOTIL

CAS NO.: 2022-85-7 , a fluorinated pyrimidine analogue, is a synthetic antifungal & antiHIV drug.

It is structurally related to the cytostatic fluorouracil and to floxuridine. It is available in oral and in some countries also in injectable form. Flucytosine was first synthesized in 1957 but its antifungal properties were discovered in 1964. The drug is dispensed in capsules of 250 mg and 500 mg strength. The injectable form is diluted in 250 mL saline solution to contain 2.5 g total (10 mg/mL). The solution is physically incompatible with other drugs including amphotericin B.

Medical uses
Oral flucytosine is indicated for the treatment of serious infections caused by susceptible strains of Candida or Cryptococcus neoformans or cryptococcal meningitis . It can also be used for the treatment of chromomycosis (chromoblastomycosis), if susceptible strains cause the infection. Flucytosine must not be used as a sole agent in life-threatening fungal infections due to relatively weak antifungal effects and fast development of resistance, but rather in combination with amphotericin B and/or azole antifungals such as fluconazole oritraconazole. Minor infections such as candidal cystitis may be treated with flucytosine alone.